ADDRESS:
Abraham E, Laterre P Garg R, Levy H, Talwar D, Benjamin L, Trzaskoma M, Francois B, Guy J, Bruckmann M, Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N, Barbara R, Utterback G, Macias W, Rajhans P, for the Administration of Drotrecogin Alfa (Activated) in Early Stage Severe Sepsis (ADDRESS) Study Group*, Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death , New England Journal of Medicine, 2005;353:1332-41.